3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
19
Unknown
8
Recruiting
5
Terminated
3
Withdrawn
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
5
Polycystic Ovary Syndrome
3
Neoplasms
2
Vocal Cord Paralysis
1
Uterine Cervical Neoplasms
1
Prostatic Neoplasms
1
Pelvic Organ Prolapse
1
Parasomnias
1
Papillomavirus Infections
1
Pain
1
Nose Neoplasms
1
Neuroendocrine Tumors
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Leiomyoma
1
Laryngeal Diseases
1
Gynecologic Cancer
1
Globus Sensation
1
Gastrointestinal Neoplasms
1
Endometrial Hyperplasia
1
Ear Neoplasms
1
Dysphonia
1
Dupuytren Contracture
1
Disease
1
Colorectal Neoplasms
1
Brain Neoplasms
1
Interventions
Bevacizumab
37
Oxaliplatin
17
Capecitabine
17
Irinotecan
15
Leucovorin
13
HMPL-013
12
Fluorouracil
12
Cetuximab
11
trifluridine tipiracil drug combination
7
irinotecan sucrosofate
6
tipiracil
5
Trifluridine
5
Specimen Handling
5
Drug Therapy
5
tislelizumab
4
Standard of Care
4
Mitomycin
4
Magnetic Resonance Spectroscopy
4
Injections
4
Folfox protocol
4
trametinib
3
toripalimab
3
pembrolizumab
3
Nivolumab
3
IFL protocol
3
Colonoscopy
3
Blood Specimen Collection
3
Biopsy
3
zanidatamab
2
sotorasib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Colorectal Neoplasms
×
Surveys and Questionnaires
×
Clear all
NCT07361575
2026-02-17
POG
Clinique Paris-Bercy
Phase NA
Not yet recruiting
230 enrolled